iShares U.S. Medical Devices ETF (NYSEARCA:IHI) Sets New 52-Week High at $59.93

iShares U.S. Medical Devices ETF (NYSEARCA:IHI)’s stock price reached a new 52-week high on Monday . The stock traded as high as $59.93 and last traded at $59.81, with a volume of 25738 shares trading hands. The stock had previously closed at $59.42.

iShares U.S. Medical Devices ETF Price Performance

The firm has a 50-day simple moving average of $56.94 and a 200 day simple moving average of $56.55. The company has a market capitalization of $5.60 billion, a PE ratio of 35.18 and a beta of 0.83.

Hedge Funds Weigh In On iShares U.S. Medical Devices ETF

Institutional investors and hedge funds have recently bought and sold shares of the stock. Envestnet Portfolio Solutions Inc. increased its stake in iShares U.S. Medical Devices ETF by 46.5% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 7,452 shares of the company’s stock worth $402,000 after buying an additional 2,364 shares during the period. TrinityPoint Wealth LLC acquired a new stake in shares of iShares U.S. Medical Devices ETF during the fourth quarter worth approximately $210,000. UBS Group AG raised its holdings in iShares U.S. Medical Devices ETF by 6.4% in the fourth quarter. UBS Group AG now owns 1,324,308 shares of the company’s stock valued at $71,473,000 after acquiring an additional 80,033 shares in the last quarter. Wells Fargo & Company MN boosted its stake in iShares U.S. Medical Devices ETF by 5.6% during the 4th quarter. Wells Fargo & Company MN now owns 1,328,701 shares of the company’s stock valued at $71,710,000 after acquiring an additional 70,238 shares during the last quarter. Finally, Corient Private Wealth LLC acquired a new position in iShares U.S. Medical Devices ETF during the 4th quarter worth $830,000.

About iShares U.S. Medical Devices ETF

The iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund that is based on the DJ US Select \u002F Medical Equipment index, a market-cap-weighted index of manufacturers and distributors of medical devices in the US. IHI was launched on May 1, 2006 and is managed by BlackRock.